TELO: Telomir Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 186.54
Enterprise Value ($M) 183.28
Book Value ($M) 3.02
Book Value / Share 0.10
Price / Book 61.84
NCAV ($M) 3.02
NCAV / Share 0.10
Price / NCAV 61.84

Profitability (mra)
Return on Invested Capital (ROIC) -6.23
Return on Assets (ROA) -386.69
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 7.20
Current Ratio 7.20

Balance Sheet (mrq) ($M)
Current Assets 3.50
Assets 3.50
Liabilities 0.49
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -3.94
Net Income -13.07

Cash Flow Statement (mra) ($M)
Cash From Operations -3.86
Cash from Investing 0.00
Cash from Financing 3.86

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-24 30,991 109,296 28.36
2024-05-23 19,953 7,637 261.27
2024-05-22 3,552 1,504 236.17
2024-05-21 1,400 4,133 33.87
2024-05-20 1,169 2,296 50.91

(click for more detail)

Similar Companies
SYBX – Synlogic, Inc. TCON – TRACON Pharmaceuticals, Inc.
TCRT – Alaunos Therapeutics, Inc. TENX – Tenax Therapeutics, Inc.
TFFP – TFF Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io